Phong Phu Pharmaceutical JSC (HNX:PPP)
Vietnam · Delayed Price · Currency is VND 18,500
+100 (0.54%)
At close: Aug 12, 2026
HNX:PPP Revenue
Phong Phu Pharmaceutical JSC had revenue of 42.14B VND in the quarter ending June 30, 2026, with 35.57% growth. This brings the company's revenue in the last twelve months to 153.34B, up 12.84% year-over-year. In the year 2025, Phong Phu Pharmaceutical JSC had annual revenue of 139.74B with 1.59% growth.
Revenue (ttm)
153.34B
Revenue Growth
+12.84%
P/S Ratio
1.06
Revenue / Employee
1.13B
Employees
204
Market Cap
162.80B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 139.74B | 2.19B | 1.59% |
| Jan 1, 2025 | 137.55B | -14.62B | -9.61% |
| Jan 1, 2024 | 152.17B | 1.60B | 1.06% |
| Dec 31, 2022 | 150.57B | 17.29B | 12.97% |
| Dec 31, 2021 | 133.29B | 17.03B | 14.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vidipha Central Pharmaceutical JSC | 979.05B |
| Ben Tre Pharmaceutical JSC | 873.41B |
| Vimedimex Medi-Pharma JSC | 812.98B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.31B |
| Central Pharmaceutical Joint Stock Company No3 | 515.53B |
| Mediplantex National Pharmaceutical JSC | 291.40B |
| Lamdong Pharmaceutical JSC | 262.06B |
| SPM Corporation | 217.45B |